Skip to main content
OpenTrials

Clinical trial condition

Adnexal Diseases

Explore clinical trials studying Adnexal Diseases. Study availability and eligibility vary by location and protocol.

3,512 public trials 681 recruiting studies
Refine in advanced search Browse all conditions

Adnexal Diseases trial results

Completed

A Phase 1/2 Study of INCB001158 in Combination With Chemotherapy in Subjects With Solid Tumors

NCT03314935

Conditions
Adnexal Diseases, Biliary Tract Cancer (BTC), Biliary Tract Diseases, +32 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • USA Mitchell Cancer Center Mobile, Alabama, United States
  • UC Davis - Comprehensive Cancer Centre Sacramento, California, United States
  • Northwest Georgia Oncology Centers Marietta, Georgia, United States
View Trial Details
Completed

Phase 1, First-in-human, Dose-finding and Expansion Study to Evaluate XmAb®808 in Combination With Pembrolizumab in Advanced Solid Tumors

NCT05585034

Conditions
Adenocarcinoma, Adnexal Diseases, Breast Diseases, +58 more
Locations
  • UCLA Hematology/Oncology Los Angeles, California, United States
  • Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Winship Cancer Institute, Emory University Atlanta, Georgia, United States
View Trial Details
Completed

A Study of DKN-01 as a Monotherapy or in Combination With Paclitaxel in Patients With Recurrent Epithelial Endometrial or Epithelial Ovarian Cancer or Carcinosarcoma

NCT03395080

Conditions
Adnexal Diseases, Carcinosarcoma, Endocrine Gland Neoplasms, +23 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • HonorHealth Scottsdale, Arizona, United States
  • Florida Cancer Specialists & Research Institute West Palm Beach, Florida, United States
  • University of Chicago Chicago, Illinois, United States
View all 17 locations
View Trial Details
Completed

A Study of Niraparib Combined With Bevacizumab Maintenance Treatment in Participants With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy

NCT03326193

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +12 more
Locations
  • GSK Investigational Site Mobile, Alabama, United States
  • GSK Investigational Site Anchorage, Alaska, United States
  • GSK Investigational Site Mesa, Arizona, United States
  • GSK Investigational Site Burbank, California, United States
View all 29 locations
View Trial Details

Related conditions